CareerPlan

Senior Director, GTM Strategy & Portfolio Planning

San Francisco - 1800 OwensFull-time$265k–$290k2026-11-07 → 2026-11-19
Hybrid · United States

Core

Own the long-term go-to-market strategy for encaleret (BridgeBio's oral CaSR negative allosteric modulator for Autosomal Dominant Hypocalcemia Type 1) and shape investment prioritization across the broader endocrine portfolio.

Role type

Senior Director, GTM Strategy & Portfolio Planning

Builds

Multi-year commercial roadmap and portfolio-level resource planning framework

Domain

Biopharma / Rare Disease / Endocrinology

Required skills

Long-range portfolio strategy, market entry sequencing, competitive intelligence, payer strategy alignment, cross-functional stakeholder alignment, forecasting infrastructure, board-level presentation

Preferred skills

MBA or advanced science degree, endocrinology or nephrology therapeutic experience, AI-powered tools adoption

Technologies

AI-powered tools

Responsibilities

Own end-to-end GTM strategy for encaleret from pre-NDA through Year 1+; Lead marketing portfolio planning across the endocrine pipeline; Partner with Value & Access and Finance to align long-term payer strategy and lifecycle planning; Partner with HCP Marketing, Patient Marketing, and KOL Engagement to ensure strategy translates to field execution; Build and govern competitive intelligence and forecasting infrastructure; Develop and present long-term GTM and portfolio strategy updates to senior leadership and the Board of Directors

Seniority

Senior Director, strategic leadership